본문 바로가기
KERD
논문KCI 등재

제2형 당뇨 마우스 모델에서 청혈플러스의 항고지혈 및 항산화효과

Hypolipidemic and Anti-oxidant Effects of Chunghyl Plus in Type II Diabetic Mice Model

유호룡|설인찬|김윤식|조현경|최고은
한의병리학회 (The Society of Pathology in Korean Medicine)|2016.06|동의생리병리학회지 (Journal of Physiology & Pathology in Korean Medicine)|제30권 제3호|pp. 164-176|DOI http://dx.doi.org/10.15188/kjopp.2016.06.30.3.164

2

조회

0

다운로드

8

인용

0

참고문헌

키워드

AtherosclerosisHyperlipidemiaAntioxidation activityChunghual-plus(Cheonghyeol-plus)
주제분류한의학

초록

This study was perfomed to investigate the effects of Chunghyul-plus(CHP) on oxidative damage and hyperlipidemia in db/db mouse. After treatment with CHP, safety in cytotoxicity, heavy metal toxicity, production of reactive oxygen species(ROS), nitric oxide (N0) and proinflammatory cytokine IL-Ib, TNF-a, IL-6 in RAW 264.7 cells. Serum total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride, insulin, GLP-1, glucose, food intake, body weight, organ weight, AST, ALT, ALP, BUN, creatine and histologic change of liver and aorta were measured in db/db mouse after oral administration of CHP. CHP showed safety in cytotoxicity and toxicity of liver and kidney for logn time administration. CHP increased the DPPH and ABTS radical scavenging activity. CHP showed significant inhibitory effect on reactive oxygen species (ROS), and showed inhibitory effect on nitiric oxide(NO) compared to control group. CHP decreased cytokine IL-6 production significantly, and decreased IL-1β and TNF-α compared to control group. CHP decreased body and organ weitht, intake food, and glucose levels compared to control group. CHP decreased total cholesterol and triglyceride significantly, and decreased LDL-cholesterol levels and increased HDL-cholesterol levels compared to control group. CHP decreased atherogenic index and cardiac risk factor significantly. CHP increased serum insulin and GLP-1 compared to control group. In histologic examination, lipophagy in the liver and aorta decreased in CHP treated mice and the cell was regular and boundary of vessel wall was clear compared to control group. These results suggest that CHP is effective in antioxidation activity and treatment and prevention of hyperlipidemia, atherosclerosis, diabetes, ischemic heart disease, stroke and other cardiocerebrovascular disease.

Abstract

This study was perfomed to investigate the effects of Chunghyul-plus(CHP) on oxidative damage and hyperlipidemia in db/db mouse. After treatment with CHP, safety in cytotoxicity, heavy metal toxicity, production of reactive oxygen species(ROS), nitric oxide (N0) and proinflammatory cytokine IL-Ib, TNF-a, IL-6 in RAW 264.7 cells. Serum total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride, insulin, GLP-1, glucose, food intake, body weight, organ weight, AST, ALT, ALP, BUN, creatine and histologic change of liver and aorta were measured in db/db mouse after oral administration of CHP. CHP showed safety in cytotoxicity and toxicity of liver and kidney for logn time administration. CHP increased the DPPH and ABTS radical scavenging activity. CHP showed significant inhibitory effect on reactive oxygen species (ROS), and showed inhibitory effect on nitiric oxide(NO) compared to control group. CHP decreased cytokine IL-6 production significantly, and decreased IL-1β and TNF-α compared to control group. CHP decreased body and organ weitht, intake food, and glucose levels compared to control group. CHP decreased total cholesterol and triglyceride significantly, and decreased LDL-cholesterol levels and increased HDL-cholesterol levels compared to control group. CHP decreased atherogenic index and cardiac risk factor significantly. CHP increased serum insulin and GLP-1 compared to control group. In histologic examination, lipophagy in the liver and aorta decreased in CHP treated mice and the cell was regular and boundary of vessel wall was clear compared to control group. These results suggest that CHP is effective in antioxidation activity and treatment and prevention of hyperlipidemia, atherosclerosis, diabetes, ischemic heart disease, stroke and other cardiocerebrovascular disease.

참고문헌 (47)

  1. "2014 Report on the cause of death statistics"[URL]
  2. "2014 National Health and Nutrition Examination Survey"[URL]
  3. Department of Internal Medicine. Seoul National University college of medicine, "SNUH Manual", pp.507~ (2014), Korea Medical
  4. The Korean Association of Internal Medicine, "Harrison's Principles of Internal Medicine", pp.1559~1564 (2006), Publication MIP
  5. Yang, Y.G., "Hwangjenaegyeong Somunyeogseog", pp.611~612 (1991), IlJung Inc
  6. Son, B.D., "Hyperlipidemia Treatment 47 Clinical Experiences", Shanghai Journal of Traditional Chinese Medicine, 8, pp.7~8 (1990)
  7. 김동현, "循環器加減方이 고지혈증 유발 白鼠에 미치는 영향", 대한한방내과학회지, 31(3), pp.526~538 (2010), 대한한방내과학회
  8. 윤현덕, "製何首烏加味方이 고지혈증 및 산화적 손상에 미치는 영향", 대한한방내과학회지, 35(3), pp.244~261 (2014), 대한한방내과학회
  9. Lee, S. J., "ACE Reduces Metabolic Abnormalities in a High-Fat Diet Mouse Model", Evidence-Based Complementary and Alternative Medicine, pp.352647~ (2015)
  10. 김민수, "단삼이 흰쥐의 식이성 고지혈증에 미치는 영향", 동의생리병리학회지, 18(2), pp.431~435 (2004), 한의병리학회
  11. Jang, W.S., "Lipid-lowering and Antioxidant Effect of Artemisia capillaris in Poloxamer-407 induced Hyperlipidemia Model in Rat", pp.2011
  12. Park, S.A., "Lipid-lowering and Antioxidant Effect of Curcuma Radix in Poloxamer 407-induced Hyperlipidemia Model in Rat", pp.2011
  13. 박성혜, "Medicinal food로 활용하기 위한 山査에 관한 연구(2)- 산사발효액이 고지방식이에 있어 지질 대사 개선에 미치는 기능성 평가 -", 동의생리병리학회지, 19(5), pp.1272~1280 (2005), 한의병리학회
  14. Committee for Guidelines for Management of Dyslipidemia, "Korean Guidelines for Management of Dyslipidemia", 3~5 (2015)
  15. 김록범, "Trends in the Incidence of Hospitalized Acute Myocardial Infarction and Stroke in Korea, 2006-2010", Journal of Korean Medical Science, 28(1), pp.16~24 (2013), 대한의학회
  16. 김현창, "Noncommunicable Diseases: Current Status of Major Modifiable Risk Factors in Korea", 예방의학회지, 46(4), pp.165~172 (2013), 대한예방의학회
  17. The Korean Academy of Clinical Geriatrics, "Principles of Geriatric Medicine", pp.232~246 (2011), Hankookbook
  18. Yensei University College of Medicine, "New Steps to Internal Medicine Cardiovascular disease", pp.171~177 (2008), Jeongdam Publishing Company
  19. Bang, H. J., "A Study on The Oriental-medical Understandling of Hyperlipidemia", The Journal of east-west medicines, 20(1), pp.25~36 (1995)
  20. 함인혜, "茵蔯蒿와 韓茵蔯이 Triton WR-1339로 유도된 고지혈증 흰쥐에 미치는 영향", 대한본초학회지, 20(1), pp.45~52 (2005), 대한본초학회
  21. 최호영, "국산과 중국산 枳實의 Triton WR-1339 유발 高脂血症 흰쥐에 대한 효능 연구", 대한본초학회지, 22(3), pp.109~116 (2007), 대한본초학회
  22. 이장천, "加味防風通聖散이 고지방식이 급여 흰쥐의 체지질구성과 항산화능에 미치는 영향", 대한본초학회지, 20(2), pp.69~75 (2005), 대한본초학회
  23. Park, J. K., "A study on the Effect of Kamijesubsungitang on Hyperlipidemia", Daejeon University, 15(1), pp.119~131 (2006)
  24. Hwang, E.G., "Effect of HMG-CoA reductase inhibitors on the liver in induced hypercholesterolemic rats", pp.2000
  25. The national college of Korean Medicine Department of Herbology, "Department of Herbolgy. Herbology", pp.369~370 (2007), Younglim Inc
  26. Arafa, H.M., "Curcumin attenuates diet-induced hypercholesterolemia in rats", Med Sci Monit, 11(7), pp.BR228~BR234 (2005)
  27. Lee, S.J., "Protective effect of a extract of Artemisia iwayomogi Kitamura. plus Curcuma longa Linne. against Hyperlipidemia and Obesity in High Fat-Diet Mice Model", pp.2012
  28. Shin, H.S., "A Study on the Atheroprotective Effect of the Water Extract of Artemisia iwayomogi Kitamura plus Curcuma longa Linne in Apolipoprotein E-deficient Mice", pp.2013
  29. Li, H. B., "Study on lipid-regulating function for the extracts and their prescriptions from Semen Cassiae and fructus crataegi", Zhong yao cai, 30(5), pp.573~575 (2007)
  30. Madamanchi, N. R., "Oxidative stress and vascular disease", Arterioscler Thromb Vasc Biol, 25(1), pp.29~38 (2005)
  31. 이해진, "加味消風散이 염증 및 아토피피부염 동물병태에 미치는 영향", 동의생리병리학회지, 28(2), pp.146~153 (2014), 한의병리학회
  32. 김형우, "포공영 추출물의 항산화 효과 및 피부 각질세포 보호효과", 대한본초학회지, 24(3), pp.103~108 (2009), 대한본초학회
  33. 김민정, "In Vitro 항산화능 측정법에 대한 특징 분석과 채소․과일 시료에 대한 적용 사례 고찰", 한국식품영양과학회지, 40(7), pp.1053~1062 (2011), 한국식품영양과학회
  34. 구강모, "고춧잎 품종별 항산화 활성과 항산화 성분", Journal of Applied Biological Chemistry, 52(2), pp.70~76 (2009), 한국응용생명화학회
  35. 이승욱, "울릉도산 산채류 추출물의 총 폴리페놀 함량 및 항산화 활성", 한국식품과학회지, 37(2), pp.233~240 (2005), 한국식품과학회
  36. Kujala, T. S., "Phenolics and betacyanins in red beetroot(Beta vulgaris) root: distribution and effect of cold storage on the content of total phenolics and three individual compound", J Agric Food Chem, 48(11), pp.5338~5342 (2000)
  37. Kim, S.I., "Antioxidant activities and death effect of cancer cells of the Lotus(Nelumbo nucifera) leaf extracts", pp.2011
  38. Channon, K. M., "Nitric oxide synthase in atherosclerosis and vascular injury: insights from experimental gene therapy", Arterioscler Thromb Vasc Biol, 20, pp.1873~1881 (2000)
  39. Yun, K. J., "Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-κB inactivation in Raw 264.7 macrophages: Possible involvement of the IKK and MAPK pathways", Int Immunophar, 8, pp.431~441 (2008)
  40. Frostegard, J., "Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory(Th1) and macrophage stimulating cytokines", Atherosclerosis, 145, pp.33~43 (1999)
  41. Dandona, P., "Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation", Circulation, 111(11), pp.1448~1454 (2005)
  42. Bunck, M. C., "Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition", Diabetes Care, 33(8), pp.1734~1737 (2010)
  43. 최홍식, "茵蔯蒿湯과 韓茵蔯蒿湯이 알코올 投與로 誘發된 흰쥐의 高脂血症과 肝 損傷의 豫防에 미치는 影響", 대한본초학회지, 21(3), pp.47~54 (2006), 대한본초학회
  44. Kinnunen, P. K., "Lipoprotein lipase and hepatic endothelial lipase: their roles in plasma lipoprotein metabolism", Atheroscler Rev, 11, pp.65~105 (1983)
  45. Castelli, W. P., "ncidence of coronary heart disease and lipoprotein cholesterol levels", JAMA, 256(20), pp.2835~2838 (1986)
  46. Kinosian, B., "Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios", J Investig Med, 43(5), pp.443~450 (1995)
  47. Prasad, K., "Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed", Circulation, 99(10), pp.1355~1362 (1999)

관련 논문AI추천

db/db mouse에서 茵蔯, 鬱金, 山査 복합추출물의 항고지혈 및 항산화 효과김윤식, 김현태, 설인찬, 유호룡대한한방내과학회 · 대한한방내과학회지2016 · 제37권 제3호益氣化瘀湯加味方이 고지방 식이로 유발된 생쥐의 항고지혈 및 항산화에 미치는 효과신용진, 전상윤한의병리학회 · 동의생리병리학회지2015 · 제29권 제5호降脂通脈飮이 항산화 활성과 高脂血 誘發 白鼠에 미치는 影響김윤식, 설인찬, 안정조, 유호룡, 조현경, 차관배대한한방내과학회 · 대한한방내과학회지2008 · 제29권 제3호製何首烏加味方이 고지혈증 및 산화적 손상에 미치는 영향김윤식, 설인찬, 유호룡, 윤현덕, 조현경대한한방내과학회 · 대한한방내과학회지2014 · 제35권 제3호청리자감탕이 Streptozotocin으로 誘發된 흰쥐의 糖尿病 및 糖尿病合倂症에 미치는 영향강석봉, 박윤식, 신현철, 윤경민, 임은영대한한방내과학회 · 대한한방내과학회지2010 · 제31권 제3호고지방 식이로 유발된 고지혈증 동물 모델에서 枸杞子加味方의 효과 연구신민구, 안가영, 전상윤, 조재준대한한방내과학회 · 대한한방내과학회지2014 · 제35권 제4호

이 간행물의 다른 논문 (8건)

의전원생·한의전원생을 위한 협진 PBL 교육 프로그램의 효과임선주, 신상우, 홍진우, 윤영주, 이상엽pp. 137-141발효옻 추출물이 흰쥐의 식이성 고지혈증에 미치는 영향김태연, 김정범pp. 142-149A549세포에서 닥나무 추출물의 미토콘드리아/Caspase 경로를 통한 Apoptosis 유도작용임규상, 우원홍, 김단희, 김태현, 문연자pp. 150-156용육조위탕 증류액이 노화 흰쥐의 간세포 및 비장세포의 항산화능에 미치는 영향이찬, 조영권, 김재홍pp. 157-163단축형 사상체질 진단 설문지(KS-15)의 검사-재검사 신뢰도 연구장은수, 김윤영pp. 177-183
원문 보기